• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经静脉导线在手术室与电生理实验室中的取出:一项对比研究。

Extraction of transvenous leads in the operating room versus electrophysiology laboratory: a comparative study.

机构信息

Department of Cardiology, University Hospital La Timone, Marseilles, France.

出版信息

Heart Rhythm. 2011 Jul;8(7):1001-5. doi: 10.1016/j.hrthm.2011.02.007. Epub 2011 Feb 9.

DOI:10.1016/j.hrthm.2011.02.007
PMID:21315840
Abstract

BACKGROUND

Although risks and life-threatening complications associated with lead extraction are well characterized, practice patterns vary regarding whether procedures are performed in an operating room (OR) or electrophysiology (EP) laboratory with cardiothoracic surgical backup.

OBJECTIVE

Our objective was to compare procedural outcomes and complications associated with lead extraction in the OR vs. EP laboratory.

METHODS

Prospectively acquired data were pooled from 2 referral centers. Lead extraction procedures were performed between 2000 and 2010, encompassing a transition phase from the OR to EP laboratory. Analyses were conducted using generalized estimating equations.

RESULTS

A total of 1,364 leads (533 OR; 831 EP laboratory) were targeted in 684 consecutive procedures, 41.2% of which were in the OR. Laser sheaths and snares were used for 699 (51.2%) and 101 (7.4%) leads, respectively. Overall, 775 (93.1%) vs. 487 (91.4%) leads were completely extracted in the EP laboratory vs. OR [odds ratio 1.3, 95% confidence interval 0.9 to 2.1]. Complications occurred in 2.24% vs. 2.84%, respectively (P = .431). Two patients died because of superior vena caval lacerations (0.29%), 1 in each group. Rapid surgical intervention was helpful in 6 (0.9%) patients [4 OR (2 subclavian vein lacerations, 1 tricuspid valve laceration, 1 tamponade); 2 EP laboratory (tamponades)], with subsequently favorable outcomes. The only independent predictor of complications was older lead age [odds ratio 1.11 per year, 95% confidence interval 1.02 to 1.20].

CONCLUSION

Lead extraction in the EP laboratory with surgical backup is associated with a similarly low rate of complications and mortality as procedures performed in the OR.

摘要

背景

虽然与铅提取相关的风险和危及生命的并发症已得到很好的描述,但关于程序是在手术室(OR)还是电生理(EP)实验室进行,是否需要心胸外科后备支持,实践模式存在差异。

目的

我们的目的是比较 OR 与 EP 实验室中铅提取的程序结果和并发症。

方法

从 2 个转诊中心前瞻性收集的数据进行汇总。铅提取程序于 2000 年至 2010 年进行,涵盖了从 OR 向 EP 实验室过渡的阶段。使用广义估计方程进行分析。

结果

共针对 684 例连续手术中的 1364 个铅(533 个 OR;831 个 EP 实验室)进行了定位,其中 41.2%的铅在 OR 中。激光鞘和套索分别用于 699(51.2%)和 101(7.4%)个铅。总体而言,EP 实验室与 OR 相比,完全提取的铅分别为 775(93.1%)和 487(91.4%)[优势比 1.3,95%置信区间 0.9 至 2.1]。并发症发生率分别为 2.24%和 2.84%(P =.431)。由于上腔静脉撕裂,2 名患者死亡(0.29%),每组 1 名。6 名患者(4 名 OR [2 名锁骨下静脉撕裂,1 名三尖瓣撕裂,1 名填塞];2 名 EP 实验室[填塞])接受了快速手术干预,结果良好。并发症的唯一独立预测因素是铅龄较大[每年优势比 1.11,95%置信区间 1.02 至 1.20]。

结论

在 EP 实验室进行铅提取,如有外科后备支持,其并发症发生率和死亡率与 OR 手术相似。

相似文献

1
Extraction of transvenous leads in the operating room versus electrophysiology laboratory: a comparative study.经静脉导线在手术室与电生理实验室中的取出:一项对比研究。
Heart Rhythm. 2011 Jul;8(7):1001-5. doi: 10.1016/j.hrthm.2011.02.007. Epub 2011 Feb 9.
2
Laser-assisted extraction of pacemaker and defibrillator leads: the role of the cardiac surgeon.激光辅助拔除起搏器和除颤器导线:心脏外科医生的作用。
Ann Thorac Surg. 2009 May;87(5):1446-50; discussion 1450-1. doi: 10.1016/j.athoracsur.2009.02.015.
3
Outcomes of patients requiring emergent surgical or endovascular intervention for catastrophic complications during transvenous lead extraction.经静脉导线拔除术中因灾难性并发症而需要紧急手术或血管内介入治疗的患者的预后。
Heart Rhythm. 2014 Mar;11(3):419-25. doi: 10.1016/j.hrthm.2013.12.004. Epub 2013 Dec 4.
4
Outcomes and Complications of Lead Removal: Can We Establish a Risk Stratification Schema for a Collaborative and Effective Approach?导线移除的结果与并发症:我们能否建立一个用于协作和有效方法的风险分层方案?
Pacing Clin Electrophysiol. 2015 Dec;38(12):1439-47. doi: 10.1111/pace.12736. Epub 2015 Sep 22.
5
Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications.经静脉导线拔除术的大型单中心单术者经验:结果与适应证的变化
Heart Rhythm. 2008 Apr;5(4):520-5. doi: 10.1016/j.hrthm.2008.01.009. Epub 2008 Jan 17.
6
Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions.在超过 5000 例慢性血管内起搏器和除颤器导联拔除的经验中,预测患者不良结局的临床因素。
Heart Rhythm. 2014 May;11(5):799-805. doi: 10.1016/j.hrthm.2014.01.016. Epub 2014 Jan 17.
7
The current practice and perception of cardiac implantable electronic device transvenous lead extraction in the UK.英国中心脏植入式电子设备经静脉导线拔除的当前实践和认知。
Europace. 2013 Jun;15(6):865-70. doi: 10.1093/europace/eus383. Epub 2012 Nov 23.
8
Extraction of superfluous device leads: A comparison with removal of infected leads.多余装置导线的拔除:与感染导线移除的比较。
Heart Rhythm. 2015 Jun;12(6):1177-82. doi: 10.1016/j.hrthm.2015.02.005. Epub 2015 Feb 7.
9
Effectiveness, safety, and long-term outcomes of non-powered mechanical sheaths for transvenous lead extraction.非动力机械鞘在经静脉导线拔除术中的有效性、安全性和长期结果。
Europace. 2018 Aug 1;20(8):1324-1333. doi: 10.1093/europace/eux218.
10
Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.经皮心内膜下心导管取出术在咨询下进行——比较 Riata、Sprint Fidelis 和未召回的植入式心脏复律除颤器导线。
Heart Rhythm. 2013 Oct;10(10):1444-50. doi: 10.1016/j.hrthm.2013.06.021. Epub 2013 Jun 28.

引用本文的文献

1
Success and safety of deep sedation as a primary anaesthetic approach for transvenous lead extraction: a retrospective analysis.深镇静作为经静脉导线拔除术主要麻醉方法的效果和安全性:回顾性分析。
Sci Rep. 2023 Dec 27;13(1):22964. doi: 10.1038/s41598-023-50372-1.
2
LECOM (Lead Extraction COMplexity): A New Scoring System for Predicting a Difficult Procedure.LECOM(导线拔除复杂性):一种用于预测困难手术的新评分系统。
J Clin Med. 2023 Dec 8;12(24):7568. doi: 10.3390/jcm12247568.
3
Assessment of the impact of organisational model of transvenous lead extraction on the effectiveness and safety of procedure: an observational study.
评估经静脉导线拔除术的组织模型对程序的有效性和安全性的影响:一项观察性研究。
BMJ Open. 2022 Dec 29;12(12):e062952. doi: 10.1136/bmjopen-2022-062952.
4
Reply.回复。
JACC Case Rep. 2022 Sep 21;4(18):1225. doi: 10.1016/j.jaccas.2022.08.002.
5
Safety and feasibility of trans-venous cardiac device extraction using conscious sedation alone-Implications for the post-COVID-19 era.仅使用清醒镇静进行经静脉心脏设备取出术的安全性和可行性——对新冠疫情后时代的启示
J Arrhythm. 2021 Sep 22;37(6):1522-1531. doi: 10.1002/joa3.12637. eCollection 2021 Dec.
6
Cardiovascular implantable electronic device lead removal in a resource-constrained setting: A single-center experience from India.资源受限环境下心血管植入式电子设备导线拔除术:来自印度的单中心经验。
Indian Pacing Electrophysiol J. 2020 Jan-Feb;20(1):8-13. doi: 10.1016/j.ipej.2019.12.002. Epub 2019 Dec 13.
7
Transvenous Lead Extractions: Current Approaches and Future Trends.经静脉导线拔除:当前方法与未来趋势。
Arrhythm Electrophysiol Rev. 2018 Aug;7(3):210-217. doi: 10.15420/aer.2018.33.2.
8
A Case of Arterial and Venous Tear during Single Lead Extraction.单根导线拔除过程中动静脉撕裂1例。
Case Rep Cardiol. 2016;2016:3836754. doi: 10.1155/2016/3836754. Epub 2016 Apr 18.
9
Creation of the sole regional laser lead extraction program serving Atlantic Canada: initial experience.创建服务于加拿大大西洋地区的唯一区域性激光导线拔除项目:初步经验
Can J Surg. 2016 Jun;59(3):180-7. doi: 10.1503/cjs.011115.
10
Interventional cardiology: cardiac device lead extraction-similar outcomes in the OR and EP laboratory.介入心脏病学:心脏装置导线拔除——手术室和电生理实验室的相似结果
Nat Rev Cardiol. 2011 May;8(5):243. doi: 10.1038/nrcardio.2011.35. Epub 2011 Mar 15.